FIELD: medicine.
SUBSTANCE: invention can be used to model transient ischemic retina. Modeling is performed by introducing the solution of endothelin-1 (ET-1).into the eye of rat. To do this, perform injection with insulin needle size 0.4×13 mm (27G) at the turn of the cut needle to the upper eyelid to the eye's equator upper-outer quadrant of the conjunctiva. Needle is driven subconjunctivally by at least half of its length in the direction of the posterior pole of the eye. Introduced through the needle is 0, 2 ml of 4·10-6 M solution of ET-1 in phosphate buffer, pH 7.4.
EFFECT: method provides adequate reproducibility transient ischemia of the retina in the experiment without damaging eye tissue and decreasing the dose of the drug.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SIMULATING TRANSIENT RETINAL ISCHEMIA IN RATS | 2015 |
|
RU2577449C1 |
METHOD FOR EYE ISCHEMIA SIMULATION | 2016 |
|
RU2620014C1 |
METHOD FOR MODELING ISCHEMIA RETINAE | 2006 |
|
RU2313312C1 |
METHOD FOR EYE TISSUE HYPOXIC DAMAGE SIMULATION WITH APOPTOSIS ACTIVATION | 2016 |
|
RU2614937C1 |
METHOD OF SIMULATING RETINAL PIGMENT EPITHELIUM ATROPHY | 2019 |
|
RU2727000C1 |
METHOD FOR CORRECTING ISCHEMIC NEUROPATHY OF THE OPTIC NERVE WITH A DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN AN EXPERIMENT | 2017 |
|
RU2663643C1 |
METHOD OF SIMULATING RETINAL PIGMENT EPITHELIUM ATROPHY | 2019 |
|
RU2709247C1 |
METHOD OF TREATING OF THE EXPERIMENTAL RETINOPATHY OF PREMATURITY | 2015 |
|
RU2598348C1 |
METHOD FOR THROMBOSIS TREATMENT IN CENTRAL VEIN OF RETINA AND ITS BRANCHES | 2007 |
|
RU2337656C1 |
METHOD FOR TREATMENT AND PROPHYLAXIS OF OPHTHALMIC DISEASE ASSOCIATED WITH EYE TISSUE ISCHEMIA | 2004 |
|
RU2268722C2 |
Authors
Dates
2016-03-10—Published
2015-04-21—Filed